Ghodrat Montazeri

Summary

Affiliation: Tehran University of Medical Sciences
Country: Iran

Publications

  1. pmc The role of mutations in core protein of hepatitis B virus in liver fibrosis
    Ashraf Mohamadkhani
    National Institute of Genetic Engineering and Biotechnology Tehran, Iran
    Virol J 6:209. 2009
  2. ncbi request reprint Liver histology and HBV DNA levels in chronically HBV infected patients with persistently normal alanine aminotransferase
    Ghodrate Montazeri
    Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
    Arch Iran Med 13:193-202. 2010
  3. ncbi request reprint Surface area: a better predictor of disease severity than the height and volume of the barium column in patients with primary achalasia
    Ghodrat Montazeri
    Digestive Disease Research Center, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran
    Eur J Gastroenterol Hepatol 18:1203-8. 2006
  4. ncbi request reprint Current treatment of chronic hepatitis B
    Ghodrat Montazeri
    Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
    Arch Iran Med 9:1-10. 2006
  5. pmc Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B
    Ghodrat Montazeri
    Digestive Disease Research Centre, Tehran University of Medical Science, Tehran, Iran
    BMC Gastroenterol 5:32. 2005
  6. ncbi request reprint Lower oesophageal sphincter pressure and timed barium oesophagogram: two objective parameters in the non-invasive assessment of primary achalasia
    G Montazeri
    Gastroenterology and Hepatology, Digestive Disease Research Center, Tehran University of Medical Science, Shariati Hospital, Tehran, Iran
    Aliment Pharmacol Ther 22:261-5. 2005
  7. ncbi request reprint Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease
    Mehdi Mohamadnejad
    Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
    Am J Gastroenterol 101:2537-45. 2006
  8. ncbi request reprint Injection of botulinum toxin before pneumatic dilatation in achalasia treatment: a randomized-controlled trial
    J Mikaeli
    Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
    Aliment Pharmacol Ther 24:983-9. 2006
  9. ncbi request reprint Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia
    J Mikaeli
    Digestive Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran
    Aliment Pharmacol Ther 15:1389-96. 2001
  10. ncbi request reprint Efficacy of botulinum toxin injection before pneumatic dilatation in patients with idiopathic achalasia
    J Mikaeli
    Achalasia Research Unit, Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
    Dis Esophagus 17:213-7. 2004

Collaborators

Detail Information

Publications11

  1. pmc The role of mutations in core protein of hepatitis B virus in liver fibrosis
    Ashraf Mohamadkhani
    National Institute of Genetic Engineering and Biotechnology Tehran, Iran
    Virol J 6:209. 2009
    ..Our data suggests that core protein mutations in CTL epitopes and C-terminal domain accompanied with higher stage of liver fibrosis may be due to alterations in the function of core protein...
  2. ncbi request reprint Liver histology and HBV DNA levels in chronically HBV infected patients with persistently normal alanine aminotransferase
    Ghodrate Montazeri
    Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
    Arch Iran Med 13:193-202. 2010
    ..We aimed to investigate the histological activity and HBV DNA levels in these patients...
  3. ncbi request reprint Surface area: a better predictor of disease severity than the height and volume of the barium column in patients with primary achalasia
    Ghodrat Montazeri
    Digestive Disease Research Center, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran
    Eur J Gastroenterol Hepatol 18:1203-8. 2006
    ..Subjective assessment of primary achalasia is not accurate. We aimed to study the utility of surface area of barium retention in the objective assessment of these patients...
  4. ncbi request reprint Current treatment of chronic hepatitis B
    Ghodrat Montazeri
    Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
    Arch Iran Med 9:1-10. 2006
    ..Treatment strategy is changing towards using prolonged combination therapy with evolving nucleoside analogues with or without an immunomodulatory agent, aiming at eradicating covalently closed circular DNA...
  5. pmc Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B
    Ghodrat Montazeri
    Digestive Disease Research Centre, Tehran University of Medical Science, Tehran, Iran
    BMC Gastroenterol 5:32. 2005
    ..It is crucial to monitor this disease more closely with a non-invasive marker in clinical trials. We aimed to evaluate the predictive value of serum hyaluronate for the presence of extensive liver fibrosis and inflammation...
  6. ncbi request reprint Lower oesophageal sphincter pressure and timed barium oesophagogram: two objective parameters in the non-invasive assessment of primary achalasia
    G Montazeri
    Gastroenterology and Hepatology, Digestive Disease Research Center, Tehran University of Medical Science, Shariati Hospital, Tehran, Iran
    Aliment Pharmacol Ther 22:261-5. 2005
    ..The non-invasive assessment of primary achalasia is not precise...
  7. ncbi request reprint Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease
    Mehdi Mohamadnejad
    Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
    Am J Gastroenterol 101:2537-45. 2006
    ..The aim of this study was to create noninvasive models to predict significant fibrosis and inflammation in chronic HBV carriers...
  8. ncbi request reprint Injection of botulinum toxin before pneumatic dilatation in achalasia treatment: a randomized-controlled trial
    J Mikaeli
    Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
    Aliment Pharmacol Ther 24:983-9. 2006
    ..Pneumatic dilatation is the first line therapy in achalasia, but half of patients relapse within 5 years of therapy and require further dilatations...
  9. ncbi request reprint Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia
    J Mikaeli
    Digestive Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran
    Aliment Pharmacol Ther 15:1389-96. 2001
    ..The efficacy of a single pneumatic dilatation is similar to that of two botulinum toxin injections...
  10. ncbi request reprint Efficacy of botulinum toxin injection before pneumatic dilatation in patients with idiopathic achalasia
    J Mikaeli
    Achalasia Research Unit, Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
    Dis Esophagus 17:213-7. 2004
    ..It seems that BT may be a meaningful enhancing factor in long-term efficacy of PD. PD with a 30 mm balloon after a BT session may resolve the need for the future higher grade PD...
  11. ncbi request reprint Pneumatic balloon dilatation in achalasia: a prospective comparison of safety and efficacy with different balloon diameters
    J Mikaeli
    Digestive Disease Research Centre DDRC, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
    Aliment Pharmacol Ther 20:431-6. 2004
    ..There is also no consensus on the optimal method for performing pneumatic dilation as regard to balloon diameter, amount and the rate inflation pressure...